Loading News...
Volver al Panel

Abbott Laboratories (ABT)

Valores intradiarios en tiempo real

Resumen del Mercado

From:
To:
ABT Intraday
No data available
SímboloABT
Fecha de SalidaMar 17, 1980
CEOMr. Robert B. Ford
Empleados a Tiempo Completo122k
SectorHealthcare
IndustriaMedical Devices
PaísUnited States
BolsaNYSE
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
Rendimiento
PeríodoRentabilidad %Cambio de Valor
1 Día
+1.14%
+1.17 US$
5 Días
-1.15%
-1.21 US$
1 Mes
+0.18%
+0.19 US$
6 Meses
+13.77%
+12.55 US$

Analizando el Mercado con IA

Evaluando los últimos 30 días de historial y métricas fundamentales de ABT...

Estadísticas Clave
Cap. de Mercado
179.44B
Relación P/E
38.55
Rend. de Div.
2.43%
Máx. 52 Semanas
$132.03
Mín. 52 Semanas
$81.97

Consenso de Analistas

CONSENSOCompra Fuerte
ALCISTA2485.7%
NEUTRAL414.3%
BAJISTA00.0%

Objetivos de Precios de Analistas a 52 Semanas

Objetivo Mín.
$100.00
Objetivo Máx.
$130.00
Actual$103.68
Objetivo Prom.$118.52

Recomendaciones de Analistas

Precio Objetivo:$118.52($100.00 - $130.00)
FirmaCalificaciónPrecio ObjetivoPotencial de AlzaFecha
Wells FargoOverweight$120.00+15.74%23/10/2026
CitigroupBuy$122.00+17.67%22/10/2026
RBC CapitalOutperform$125.00+20.56%22/10/2026
Wells FargoOverweight$119.00+14.78%22/10/2026
JP MorganOverweight$118.00+13.81%22/10/2026
TD CowenBuy$118.00+13.81%22/10/2026
BairdOutperform$123.00+18.63%22/10/2026
BTIGBuy$125.00+20.56%22/10/2026
TD CowenBuy$135.00+30.21%16/10/2026
BarclaysOverweight$120.00+15.74%7/10/2026
Pensamientos de la Comunidad

Comparta su análisis y sentimiento sobre ABT

Únase a la comunidad para compartir su análisis